Virax Biolabs Group Limited
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
/ 
Frequently asked questions
To buy Virax Biolabs Group Limited stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Virax Biolabs Group Limited by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Virax Biolabs Group Limited is VRAX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Virax Biolabs Group Limited has its primary listing on NASDAQ (Small cap). You can trade Virax Biolabs Group Limited with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Virax Biolabs Group Limited is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Virax Biolabs Group Limited as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Virax Biolabs Group Limited.